Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells

Blood. 1997 Aug 1;90(3):974-85.

Abstract

Hematopoietic progenitor cells (HPC) from mice nullizygous at the Fanconi anemia (FA) group C locus (FAC -/-) are hypersensitive to the mitotic inhibitory effects of interferon (IFN-gamma). We tested the hypothesis that HPC from the bone marrow of Fanconi group C children are similarly hypersensitive and that the fas pathway is involved in affecting programmed cell death in response to low doses of IFN-gamma. In normal human and murine HPC, IFN-gamma primed the fas pathway and induced both fas and interferon response factor-1 (IRF-1) gene expression. These IFN-gamma-induced apoptotic responses in HPC from the marrow of a child with FA of the C group (FA-C) and in FAC -/- mice occurred at significantly lower IFN doses (by an order of magnitude) than did the apoptotic responses of normal HPC. Treatment of FA-C CD34+ cells with low doses of recombinant IFN-gamma, inhibited growth of colony forming unit granulocyte-macrophage and burst-forming unit erythroid, while treatment with blocking antibodies to fas augmented clonal growth and abrogated the clonal inhibitory effect of IFN-gamma. Transfer of the normal FAC gene into FA-C B-cell lines prevented mitomycin C-induced apoptosis, but did not suppress fas expression or inhibit the primed fas pathway. However, the kinetics of Stat1-phosphate decay in IFN-gamma-treated cells was prolonged in mutant cells and was normalized by transduction of the normal FAC gene. Therefore, the normal FAC protein serves, in part, to modulate IFN-gamma signals. HPC bearing inactivating mutations of FAC fail to normally modulate IFN-gamma signals and, as a result, undergo apoptosis executed through the fas pathway.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anemia, Aplastic / etiology
  • Anemia, Aplastic / physiopathology
  • Animals
  • Annexin A5 / metabolism
  • Apoptosis / drug effects
  • Apoptosis / genetics*
  • Cell Cycle Proteins*
  • Cells, Cultured
  • DNA, Complementary / genetics
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / physiology
  • Fanconi Anemia / complications
  • Fanconi Anemia / genetics*
  • Fanconi Anemia / physiopathology
  • Fanconi Anemia Complementation Group C Protein
  • Fanconi Anemia Complementation Group Proteins
  • Fas Ligand Protein
  • Genetic Complementation Test
  • Hematopoietic Stem Cells / drug effects*
  • Humans
  • Interferon Regulatory Factor-1
  • Interferon-gamma / pharmacology
  • Membrane Glycoproteins / genetics
  • Membrane Glycoproteins / physiology
  • Mice
  • Mice, Knockout
  • Mitomycin / pharmacology
  • Nuclear Proteins*
  • Phosphoproteins / genetics
  • Phosphoproteins / physiology
  • Proteins / genetics
  • Proteins / physiology*
  • Recombinant Proteins
  • Signal Transduction
  • Transfection
  • fas Receptor / genetics
  • fas Receptor / physiology

Substances

  • Annexin A5
  • Cell Cycle Proteins
  • DNA, Complementary
  • DNA-Binding Proteins
  • FANCC protein, human
  • FASLG protein, human
  • Fancc protein, mouse
  • Fanconi Anemia Complementation Group C Protein
  • Fanconi Anemia Complementation Group Proteins
  • Fas Ligand Protein
  • Fasl protein, mouse
  • IRF1 protein, human
  • Interferon Regulatory Factor-1
  • Irf1 protein, mouse
  • Membrane Glycoproteins
  • Nuclear Proteins
  • Phosphoproteins
  • Proteins
  • Recombinant Proteins
  • fas Receptor
  • Mitomycin
  • Interferon-gamma